Li Liao
- Molecular Biology top 5%
- Genetics top 0.5%
- Cancer Research top 2%
- Surgery top 10%
- Biomedical Engineering top 10%
- Topics
- Mesenchymal stem cell research (27 papers)MicroRNA in disease regulation (23 papers)Bone Metabolism and Diseases (13 papers)
- Cited by
- GeneticsCancer ResearchUrology
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Li Liao
97 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Molecular Biology 1.9k
- Genetics 1.1k
- Cancer Research 869
- Surgery 429
- Biomedical Engineering 393
Countries citing papers authored by Li Liao
This map shows the geographic impact of Li Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Liao more than expected).
Fields of papers citing papers by Li Liao
This network shows the impact of papers produced by Li Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Liao. The network helps show where Li Liao may publish in the future.
Co-authorship network of co-authors of Li Liao
This figure shows the co-authorship network connecting the top 25 collaborators of Li Liao. A scholar is included among the top collaborators of Li Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Liao. Li Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 10 | |
| 10 | 8 | |
| 11 | 19 | |
| 12 | 20 | |
| 13 | 15 | |
| 14 | 17 | |
| 15 | 58 | |
| 16 | 42 | |
| 17 | 1 | |
| 18 | 114 | |
| 19 | Transplanted mesenchymal stem cells can inhibit the three developmental stages of murine acute graft-versus-host disease. | 5 |
| 20 | The Oryza Map Alignment Project | 2 |
About Li Liao
Li Liao is a scholar working on Genetics, Cancer Research and Urology, having authored 101 papers that have together received 3.7k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (27 papers), MicroRNA in disease regulation (23 papers) and Bone Metabolism and Diseases (13 papers). The work is most often cited by research in Genetics (1.1k citations), Cancer Research (869 citations) and Urology (313 citations). Li Liao has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yan Jin, Xiaoxia Su, Weidong Tian, Bei Li, Yi Shuai, Cheng‐Hu Hu, Shiyu Liu, Xiaoning He, Huan Jing and Zhihong Deng. Their work appears in journals such as Advanced Materials, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.